Junior Faculty Development awards are designed to support early investigators of outstanding promise as they establish independent, productive careers in diabetes research.
Applicants must hold a full-time independent faculty position up to and including Assistant Professor at a university, university-affiliated research institution or other non-profit research institution in the United States. If an appointment is less than full-time, this must be noted within the application’s budget justification. Applications from investigators with less than a full-time appointment will be considered on a case-by-case basis.
The applicant should have no more than ten (10) years of research experience following receipt of their terminal degree.
However, applicants who have taken temporary leave from research (i.e. all clinical training, parenting of a child, childbirth, long-term care of a parent/spouse/child/dependent, personal health issues), or experienced a delay in their training due to COVID shutdowns; are encouraged to contact ADA Research Programs staff regarding their eligibility ahead of their application submission. The Association aims to be flexible and adjust these eligibility timeframes, if necessary and appropriate.
Applicants cannot currently hold or have previously received independent NIH project support as Principal Investigator (e.g., NIH R00, R01, U01 or the equivalent). During the duration of this award, if an R01, U01 or the equivalent is obtained then the applicant may hold both awards concurrently, provided there is no scientific or budgetary overlap.
Applicants may not hold an ADA Junior Faculty Development Award concurrently with other awards of similar intent (i.e., NIH K award series, including K99; other foundation/non-profit development awards). However, the applicant may have completed previous career development funding.
Eligible Countries:
Sponsor Institute/Organizations: American Diabetes Association
Sponsor Type: Corporate/Non-Profit
Address: 2451 Crystal Dr Ste 900. Arlington, VA 22202
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 04, 2025
Feb 19, 2026
$414,000
$138,000 USD per year for a maximum total budget up to $414,000 USD over three (3) years
Affiliation: American Diabetes Association
Address: 2451 Crystal Dr Ste 900. Arlington, VA 22202
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.